is necessary to assess treatment effects. The PROMIS instruments were developed with individually calibrated items, providing a sensitivity to change 4 times greater than possible through other test development methods. 15 The PROMIS instruments were validated during the development process on a general population, but like all PRO instruments, they can be improved by testing longitudinally on clinical populations and in specific diagnostic or treatment groups. Responsiveness to a general population does not automatically ensure responsiveness in a specific clinical population. Longitudinal studies with data collected from multiple time points on the same individuals using the same PROs are necessary to determine responsiveness to treatment-related change. 44 This data collection takes time and the PROMIS instruments are new, so clinical studies assessing whether the PROMIS instruments are able to detect change are still needed.
Responsiveness can be assessed with both internal and external methods. Internal measures of responsiveness assess change from a baseline score to a follow-up score, providing valuable information about whether an instrument has detected a change and the magnitude of the change. 25 Because internal responsiveness uses the measure itself as the measuring stick for change, it does not automatically provide information on whether the change might be considered meaningful. External responsiveness addresses this limitation with a comparison of the instrument to a standard that anchors the amount of change to some other health measure. 25 The comparison might be made to a gold standard in treatment, a long-used clinical tool, physical examination, or any method that links the current treatment response to an alternative indicator of the patient's condition. 51 PROMIS measures are available for a number of domains, with pain and function as 2 domains specifically relevant to orthopedic practice. Prior research has demonstrated that function and pain, while related, are only moderately correlated. 11 This difference indicates a uniqueness between the 2 constructs and emphasizes the importance of assessing changes in pain and function individually. For this reason, both the PROMIS PF and PROMIS PI were selected for evaluation. It is also useful to compare newer measures with existing instruments; thus, the Foot and Ankle Ability Measure (FAAM) Sports was selected for evaluation as well.
Given the recent development of PROMIS instruments, there has been limited investigation into the PF and PI instrument responsiveness in orthopedics. Initial investigation of responsiveness of PROMIS measures has shown that the PROMIS PF-20 outperformed older instruments (i.e., the Health Assessment Questionnaire [HAQ] Disability Index and the PF-10) in terms of responsiveness in a sample of 1000 individuals with rheumatoid arthritis. The PROMIS PF-20 detected a 1.2% difference at 80% power compared with the best legacy test with a 2.3% difference at 80% power. 15 In that analysis, the authors concluded that the sensitivity of the PROMIS instruments allows for smaller sample sizes in research without a loss of power due to their superior ability to detect change. Another study of 451 individuals with rheumatoid arthritis found the PROMIS-PF 20 to be more responsive than 2 other legacy measures of physical function (SF-36 and the HAQ). 19 The FAAM Sports subscale is a targeted instrument developed to assess foot and ankle pathologies in clinical practice. 34 It has shown good correlation with PROMIS instruments. 38, 39, 47 Initial validation of the FAAM Sports showed that its subscale was more responsive to change at 4 weeks than a general measure of physical function, 35 and generally responsive to change at 6 months. 21 Further validation studies are needed to assess the responsiveness of the PROMIS instruments and FAAM Sports within specific clinical populations and contexts. 1 The purpose of this study was to evaluate the responsiveness of the FAAM Sports and the 2 PROMIS item banks (PI and PF) administered by CAT to patients with foot and ankle problems. This study asked, "How responsive are the PROMIS PF and the FAAM Sports to changes in patients' report of function?" and "How responsive is the PROMIS PI to changes in patients' report of pain?"
Methods

Study Design
Meaningful change was defined as any patient-perceived improvement or worsening in condition, so only patients reporting improvement or deterioration (little/some/great relief/improvement or little/some/great deterioration/worsening) were included in each analysis. Individuals reporting worsening symptoms have shown evidence of lower levels of change from baseline, 13, 50 and many measures have been found to be less responsive to deterioration than improvement. 18, 20, 33, 36, 49 One approach to handling the difference in positive or negative change is to evaluate improvement separately from deterioration. 2, 3, 9, 14, 37 The main focus of this study was to assess positive change in order to examine responsiveness to improvement. There was a small sample who reported worsening symptoms, examined as a secondary analysis for the purpose of verifying whether the scores were dropping when symptoms were worsening. Institutional review board approval was obtained prior to the start of this study.
Four sequential follow-up periods were examined in this study: (1) 3-month follow-up (80 to 100 days after initial assessment); (2) >3-month follow-up (90 days or more after initial assessment); (3) 6-month follow-up (170 to 190 days after initial assessment); and (4) >6-month follow-up (180 days or more after initial assessment). Three and 6-month follow-up periods are common in orthopedic practices, 4, 8, [29] [30] [31] [32] 41, 48 at times measured in terms of periods extending past the 3-and 6-month follow-ups. 17, 27, 46 These time points were included in this study to correspond with prior literature and clinical practice.
Participants
This study consisted of 785 consecutive patients presenting to an academic foot and ankle clinic with a minimum of 2 visits greater than 3 months apart between 2014 and 2017. All patients sought treatment for foot and ankle musculoskeletal conditions and were aged 18 years or older at the time of baseline assessment. Demographic questions and PRO instruments were administered on handheld tablet computers at the first clinic visit immediately prior to their appointment. Because patients reported their level of change in pain or function (which were used here as the external anchors) at each visit, the anchor responses might change or differ for each visit. Different patient samples might also be included in the analysis for each follow-up period as not all patients returned for follow-up visits at identical intervals of time.
Inclusion of patients in the sample for each analysis, for each measure at each time point, was dependent on whether there were nonmissing responses to an anchor question about either function or pain. Change levels for the PROMIS PF and FAAM Sports analyses were anchored by patient responses to the question: "Compared to your FIRST EVALUATION at the xx Center: how would you describe your PHYSICAL FUNCTION LEVEL now?" (much worse, worse, slightly worse, no change, slightly improved, improved, much improved). Similarly, the PROMIS PI consisted of the following anchor question: "Compared to your FIRST EVALUATION at the xx Center: how would you describe your episodes of PAIN now?" (much worse, worse, slightly worse, no change, slightly improved, improved, much improved). This type of anchor question is referred to as a global rating of change (GRC) scale, is a recommended anchor for evaluating PROs, 43 and has been commonly used in orthopedics. 28 The GRC was only used as an anchor, relating levels of change to patient-perceived improvement, ensuring that responsiveness could be assessed in terms of meaningful change from a patient perspective.
This study included a total of 785 patients: 471 women and 314 men with ages ranging from 18 to 91 years old (mean age = 52, SD = 17). The majority of patients were white (n = 707, 90.1%). Full demographic information is displayed in Table 1 . There were 43 different diagnostic conditions in this foot and ankle population that precluded stratification by procedure groupings. Procedures included a range of services, such as amputations, fusions, reconstructions, repairs, arthroplasty, bunionectomy, and tendon transfers, among other treatments.
Instruments
The PROMIS PF v1.2 CAT and the PROMIS PI v1.1 CAT were administered to consecutive patients seeking treatment between 2013 and 2017. The FAAM Sports was administered, in addition to the PROMIS instruments, to all patients seeking treatment between 2016 and 2017, resulting in a smaller sample size of FAAM Sports administrations. The PROMIS PF v1.2 contains both upper extremity and lower extremity items and draws from a 121-item test bank. The PROMIS PI v1.1 has a 40-item test bank. The FAAM is constructed with 2 subscales, the 21-item AD subscale and the 8-item Sports subscale. Only the Sports subscale was administered as relevant to the orthopedic population being evaluated in our clinics. The PROMIS instruments have been developed with a standardized scoring mechanism with a mean of 50 and a standard deviation (SD) of 10 in the t score scale. 45 All PROMIS items and measures were calibrated among the general population, with some oversampling among specific groups. 6 Higher levels of function are represented by higher scores on the PROMIS PF, and higher levels of pain interference with daily activity are represented by higher scores on the PROMIS PI. FAAM Sports items are scored on a 5-point scale from 0 (unable to do) to 4 (no difficulty at all), for a total score range from 0 to 32, with raw scores transformed into percentage scores 34 so that higher percentage scores reflect higher levels of function. Administration of these instruments was through the mEVAL-a webbased application maintained by the University of Utah. The PROMIS CAT algorithms were set at default (see http:// www.healthmeasures.net). Administration occurred at baseline (either within 7 days prior to the clinic visit of a new foot and ankle condition or on the day of the first clinic visit) and at each follow-up visit patients attended.
Statistical Analyses
Analyses of patient demographic characteristics were performed using descriptive statistics. Change scores represented the difference between the baseline score and the follow-up score compared at 3 months (90 days ± 10 days, and 90 days and beyond) and 6 months (180 days ± 10 days, and 180 days and beyond) on the PROMIS PF, PROMIS PI, and FAAM Sports. One-way analysis of variance (ANOVA) examined the discriminative ability of the anchor question and the outcome scores at each time point, anchoring the PROMIS and FAAM Sports change scores to the patients' own reports of change during the treatment period. Paired sample t tests were used to test the hypothesis that there was no change in the outcomes between time points, tested both for change groups and for measures at each follow-up point. The significance level was set at .05, 2-sided. Paired sample t tests were appropriate for evaluation of relationships between 2 continuous variables, such as pre-and post-PROMIS scores.
Cohen's d was used as a standardized measure of effect size (ES), addressing variability that exists in scores, which is not included in the mean difference comparisons of the t test. 25 Cohen's d removes the dependence on sample size and is normalized based on the cross-sectional SD of scores, calculated as the difference between the baseline score and the follow-up score, divided by the baseline score's SD. In interpreting Cohen's d, a small ES is approximately d = 0.20, whereas d = 0.50 is considered a medium effect, and a large ES can be considered d = 0.80. An ES of 0.80 represents a large change where the difference is as least as great as four-fifths of an SD in scores. 9 The standardized response mean (SRM) is similar to the paired t test, but this calculation removes the dependence on sample size from the equation 25 and is normalized based on the SD of the change score. SRM is calculated as the mean difference between baseline and follow-up scores divided by the SD of difference scores, reflecting individual changes in scores.
Recommended 
Results
Descriptive statistics of the PROMIS PF, PROMIS PI, and FAAM Sports are presented in Table 2 for the improved and deteriorated groups. Inclusion criteria required a follow-up instrument score and anchor question response within the specified time window of the period. For the PROMIS PF, there were between 6491 and 8681 clinic patients who were not eligible for inclusion in each analysis. The non-followup group had baseline PROMIS PF scores ranging from 2 to 4 points higher than those in the follow-up window, suggesting higher function within this group. For the PROMIS PI, the 3545 to 4795 patients not having follow-up within the analyzed time windows had baseline PI scores that were an average of 2 to 3 points lower than those within the follow-up periods, indicating less pain interference. The 1795 to 2156 nonparticipants for the FAAM Sports had baseline scores that were 6 to 14 points higher on average, indicating higher function.
One-way ANOVA between the anchor question and the PROMIS PF at the 3-month follow-up was significant (F (6, 67) = 2.42, P = .035), providing evidence of discrimination between groups and showing that the improving group had higher function than the worsening group. The PROMIS PF showed significant Spearman correlations with the anchor questions at follow-up, though the 6-month correlations were lower. Spearman correlations were used due to the ordinal nature of the anchor questions. The associations between the PROMIS PF and the anchor questions were r = 0.423 (P < .001) at the 3-month, r = 0.233 (P = .005) at the >3-month, r = 0.363 (P = .068) at the 6-month, and r = 0.111 (P = .287) at the >6-month follow-ups. For those who improved, the PROMIS PF had significant change scores measured by paired sample t tests at the 3-month follow-up (P = .044), but they were not significant at the other time points. For the deteriorated group, there was no significant difference at the 3-month, 6-month, and >6-month follow-ups, and only the >3-month follow-up time point was significant (P = .017). Full results are presented in Table 3 . The ES was large for all time points for the PROMIS PF, with values of 0.99, 0.96, 1.22, and 0.95 (3, >3, 6, and >6 months), respectively. The deteriorated group showed medium to large ESs for the PROMIS PF with 0.85, 0.74, 1.11, and 0.70 at the respective time points. The PROMIS PF had SRM values of 1.43, 1.17, 1.05, and 1.04 across the 4 time points (3, >3, 6, and >6 months), respectively. Similarly, the deteriorated group also showed high SRM values of 1.28, 1.08, 1.43, and 1.03, respectively.
The results for the one-way ANOVA between the anchor question and the PROMIS PI at the 3-month follow-up were significant (F (6, 98) = 4.95, P < .001). One-way ANOVA between the anchor questions and the other time points (i.e., >3-month and >6-month follow-ups) showed statistically significant differences with the exception of the 6-month follow-up period due to low sample size in the deteriorated group. The PROMIS PI showed significant Spearman correlations with the anchor questions at the 3-month (r = −0.552, P < .001), >3-month (r = −0.362, P < .001), 6-month (r = −0.400, P = .026), and >6-month (r = −0.216, P = .019) follow-ups. For those who improved, the PROMIS PI had significant change scores as measured by paired sample t tests at the 3-month follow-up (P < .001), >3-month follow-up (P < .001), and >6-month follow-up (P < .001). For the 6-month follow-up, the change scores were not significant, likely due to low sample size. For the deteriorated group, t tests of change scores for the PROMIS The relationship between the anchor questions and the FAAM Sports at the 3-month follow-up as demonstrated by the one-way ANOVA was significant (F (6, 74) = 2.99, P = .011). The >3-month follow-up and the >6-month followup were also statistically significant, though the 6-month follow-up period was not, likely due to low sample size in the deteriorated group. The FAAM Sports showed significant Spearman correlations with the anchor questions at the 3-month (r = 0.353, P < .001) and >3-month (r = 0.292, P < .001) follow-ups, though not at the 6-month (r = 0.026, P = .905) and >6-month (r = 0.104, P = .622) follow-ups. For the improved group, the FAAM Sports had significant change scores at the 3-month (P = .001), >3-month (P < .001), and >6-month (P < .001) follow-ups, though not for the 6-month follow-up, likely due to a low sample size of 16. The deteriorated group showed a significant change score at the 3-month follow-up (P = .040) and at the >3-month follow-up (P = .001), whereas no significant change was demonstrated at the 6-month and >6-month follow-ups. The ES was large for the FAAM Sports, with values of 1.31, 1.25, 1.30, and 1.28, respectively, across the 4 time points. The deteriorated group showed medium to large ESs of 1.01, 1.24, 0.75, and 0.62, respectively. The FAAM Sports showed similarly high SRM values of 1.16, 1.20, 1.07, and 1.11, respectively, for the improved group. Similarly, the deteriorated group also showed high SRMs of 1.62, 1.28, 1.24, and 0.88. Detailed information is presented in Table 3 .
Discussion
This study examined the responsiveness of the PROMIS PF, PROMIS PI, and FAAM Sports in patients with foot and ankle musculoskeletal conditions. Prior literature has stated that the PROMIS instruments, such as the PROMIS PF, have shown high responsiveness and strong psychometric properties, and have outperformed other legacy measures of physical function. 19, [22] [23] [24] Findings from this current study suggest that the PROMIS PF exhibited high responsiveness to change with a large ES and SRM among a lower extremity population. Though the PROMIS PF was more responsive than the FAAM Sports for the improved group, it was less responsive than the FAAM Sports for the deteriorated group. The PROMIS PI has had limited investigation into responsiveness in prior research. This study was able to establish that the PROMIS PI was highly responsiveness to change, where large ESs and SRMs were observed that were larger for the improved group than for the deteriorated group. This finding is consistent with prior research regarding the measurement of responsiveness to deterioration, that instruments tend to be less responsive to deterioration overall. 18, 20, 33, 36, 49 In terms of paired sample t test significance, the PROMIS PI demonstrated significant change for the improved group, but not for the deteriorated group. The FAAM Sports also showed high responsiveness for the improved group as well as medium to high responsiveness for the deteriorated group. The FAAM Sports was the only measure evaluated that showed significant responsiveness to change among the deteriorated group, though only at the 3-month and >3-month follow-up points.
The significant one-way ANOVA at the 3-month followup provides empirical evidence that the deteriorated group of patients had the lowest PROMIS PF and FAAM Sports scores, as would be expected, and the improved group had the highest PROMIS PF and FAAM Sports scores. The significant one-way ANOVA between the pain anchor question and 3-month follow-up PROMIS PI also showed evidence of validity of the anchor question used in this study. The PROMIS PF, PROMIS PI, and FAAM Sports all demonstrated meaningful changes among individuals who sought follow-up treatment at the clinic.
Utilizing 3 different methods, we found that the ES method identified medium to high responsiveness with values greater than 0.62 for all 3 instruments at 4 different follow-up periods for both the improved and deteriorated groups. Similarly, the SRM method indicated a large effect, with values greater than 0.88 for all instruments and groups at all time points evaluated. On the other hand, the paired sample t tests provided nonsignificant results at times when the sample sizes were low. This implies that the results from the ES and SRM methods are more trustworthy than the paired sample t test in the evaluation of responsiveness, since the ES and SRM methods are not sample size dependent. This study also included varying follow-up time points, which is important for cross-validation and understanding of the robustness of the findings.
Limitations
A potential limitation to this study is that the clinic sample had different patients with varying diseases and conditions, but we were unable to stratify by procedure code due to limited sample size for each procedure. Future studies may consider stratification if sufficient sample size can be obtained. Future research that is able to stratify the data by specific procedure codes might enhance our understanding of the sensitivity of the PROMIS PF and PROMIS PI to specific orthopedic clinical populations. Additionally, the demographics of the clinic sample may not be representative of the US population and may not be considered generalizable beyond the sample characteristics.
In this study, change was anchored with the use of global reports that rely on retrospective recall of prior function and may be subject to recall bias. A potential problem with GRC is that it relies on retrospective reflection, which may be only weakly correlated with treatment effect. 40 Reports of change may be more related to the current health status than the baseline change value. 7 However, in this study the repeat measures of the PROs at follow-up were used to document changes in condition and were not subject to recall bias as measures of both baseline and current functioning, limiting the role of recall bias in the analysis. Another concern is that patients who return to the clinic for the longer-term visits may be more likely to come for continued pain or functional limitations and may not reflect the clinic population as a whole. This might result in a follow-up sample that does not capture the full range of outcomes, but is skewed in severity. Average PROMIS PF, PROMIS PI, and FAAM Sports scores for those clinic patients not included within each follow-up time period analyzed showed higher levels of function and less pain than the analyzed group. However, our sample is typical in orthopedic clinics, relevant to our clinical practice, and may be generalizable to other similar clinical practices. Future studies examining responsiveness for specific conditions and across different populations are recommended.
Conclusion
This study was able to determine the PROMIS PF, PROMIS PI, and FAAM Sports responsiveness to change. These instruments showed medium to high responsiveness to change regardless of the different indices across 4 follow-up periods. Results from this study can be used alongside other peer-reviewed studies for clinicians and researchers wanting to further confirm their decisions in selecting the most efficient and effective instruments to measure patient outcomes. The minimized respondent burden with CAT administration of the PROMIS measures makes them a preferred or desirable measurement tool where available. Our findings of responsiveness are important in advancing treatment protocols and give clinicians and researchers the knowledge to most effectively and efficiently interpret outcome measures.
